KA

Kiran Appasaheb Patil

Director Director DIN 07115804
DIN 07115804 First appointment May 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2015
Shareholding value Locked Premium profile

About Kiran Appasaheb Patil

Kiran Appasaheb Patil has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 07115804
Primary Designation Director
First Appointment 05 May 2015
Oldest Company Age 11 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Mael Pharma Private Limited U24233PN2015PTC154919
Director 05 May 2015 2015 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mael Pharma Private Limited
Premium access

Shareholding and investment profile for Kiran Appasaheb Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Appasaheb Patil

Kiran Appasaheb Patil has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Kiran Appasaheb Patil is associated with 0 companies as Director.

Kiran Appasaheb Patil has expertise in General Business.

Kiran Appasaheb Patil has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available